Dr. Thomas So Talks Diabetes & Obesity Drugs, Clinical Trials
Thomas So, PharmD, a clinical pharmacist and Sr. Manager of Consumer Drug Information Group at FDB (First Databank), discusses diabetes and obesity drugs currently on the market and related clinical research.
Native Hawaiian and Pacific Islander Adults Suffer Second Highest Cardiovascular Death Rate in the US
Lower Overall Reponse Rates to Idecabtagene Vicleucel in Hispanic Patients With Multiple Myeloma
Advanced Age, Financial Constraints Contribute to Higher Ibrutinib Discontinuation Rates in Medicare Recipients
630 Madison Ave.
Manalapan, NJ 07726
Contributors & Partners
Work With Us
GU Oncology Now
Blood Cancers Today
Cancer Nursing Today
© 2023 Mashup Media, LLC. All rights reserved.